Finding the right gift for your girlfriend is not about choosing something expensive or trendy. It is about picking something that feels thoughtful and personal.
News in Focus
Kotak Mahindra Bank’s third-quarter performance for FY26 reinforces a familiar but increasingly convincing narrative: steady earnings delivery, disciplined balance sheet growth, and visible stabili
Featured, Analyst View, Futures & Options, Stock Markets, Banking Sector, Axis Bank, ICICI Direct, India
Axis Bank’s Q3FY26 performance marks a return to earnings normalcy, free of one-off distortions, even as margin pressures persist in a shifting rate environment.
Coforge Limited delivered a mixed operational performance in Q3FY26, missing revenue and profitability estimates, yet reinforcing its long-term investment thesis through a sharply expanding order b
DLF's Q3FY26 performance may appear underwhelming at first glance, but a deeper examination suggests that the company’s long-term growth trajectory remains firmly intact.
Axis Securities has reiterated its BUY call on Kotak Mahindra Bank Limited, assigning a target price of Rs 515, implying an upside of 22% from current levels.
Main Regional Stories
Indian Bank’s Q3FY26 performance underscores a phase of measured consolidation rather than aggressive expansion.
Dr Reddy’s Laboratories is navigating a critical transition phase as legacy gains from gRevlimid taper off, even as the company lays the groundwork for its next multi-year growth cycle.
UltraTech Cement, India’s largest cement manufacturer, continues to outpace industry growth as capacity expansion, operational efficiencies, and infrastructure-led demand converge into a multi-year growth cycle.
Featured, Analyst View, Stock Markets, BP Equities, Gujarat, Gujarat Themis Biosyn, India, Pharmaceutical Sector
Gujarat Themis Biosyn Limited (GTBL), a niche pharmaceutical manufacturer specializing in fermentation-based intermediates, is entering a decisive phase of strategic evolution. BP Equities Pvt. Ltd.
